| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 780 |
| 1 | PREDNISONE | 146 |
| 2 | RISANKIZUMAB-RZAA | 109 |
| 3 | OMEPRAZOLE MAGNESIUM | 79 |
| 4 | INFLIXIMAB | 77 |
| 5 | VEDOLIZUMAB | 76 |
| 6 | ERGOCALCIFEROL | 72 |
| 7 | OMEPRAZOLE | 70 |
| 8 | CLOZAPINE | 56 |
| 9 | AZATHIOPRINE | 55 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | 1 | 0.0417 |
| 1 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 2 | 0.0116 |
| 2 | INFLIXIMAB-DYYB | 33 | 0.0096 |
| 3 | ONTRUZANT | 4 | 0.0077 |
| 4 | PSYLLIUM HUSK | 9 | 0.0067 |
| 5 | STREPTOMYCIN | 5 | 0.0044 |
| 6 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 3 | 0.0033 |
| 7 | CANDIDA ALBICANS | 2 | 0.0031 |
| 8 | CLORAZEPATE DIPOTASSIUM | 6 | 0.0030 |
| 9 | HALOPERIDOL DECANOATE | 5 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 240 |
| 1 | Interleukin-23 Antagonist [EPC] | 151 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 140 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 118 |
| 4 | Proton Pump Inhibitor [EPC] | 113 |
| 5 | Benzodiazepine [EPC] | 110 |
| 6 | Atypical Antipsychotic [EPC] | 107 |
| 7 | Platinum-based Drug [EPC] | 96 |
| 8 | Integrin Receptor Antagonist [EPC] | 85 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 85 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 2 | Provitamin D2 Compound [EPC] | 72 | 0.0024 |
| 3 | GLP-2 Analog [EPC] | 28 | 0.0021 |
| 4 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 3 | 0.0020 |
| 5 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 6 | Interleukin-23 Antagonist [EPC] | 151 | 0.0014 |
| 7 | Non-Standardized Fungal Allergenic Extract [EPC] | 3 | 0.0014 |
| 8 | Phosphate Binder [EPC] | 3 | 0.0010 |
| 9 | Integrin Receptor Antagonist [EPC] | 85 | 0.0010 |